- 8 July 2026
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 50 (10) , 1139-1151
Abstract
So-called hybrid oncocytic tumor (HOT) is the renal neoplasm most commonly associated with the germline folliculin ( FLCN ) mutations that define Birt-Hogg-Dubé syndrome. However, the spectrum of renal epithelial neoplasms associated with FLCN gene mutations has recently expanded to include neoplasms with somatic FLCN mutations and those with variant morphology. Some of these FLCN -mutated neoplasms overlap morphologically and immunohistochemically with TSC/MTOR -mutated and TFE3/TFEB fusion renal cell carcinomas, which makes sense given their overlapping genetic pathways. One morphology that has been reported in 1 to 2 cases each across multiple studies is that of a “histiocyte-rich” renal epithelial neoplasm, characterized by acinar spaces lined by neoplastic oncocytic epithelial cells variably distended by luminal histiocytes. An unanswered question is how frequently this morphology is associated with FLCN mutations. We identified 11 previously unreported cases of histiocyte-rich renal epithelial neoplasms and performed immunohistochemistry and next-generation sequencing. Five out of 11 cases (45%) demonstrated FLCN mutations, including at least 3 cases with evidence supporting occult Birt-Hogg-Dubé syndrome. All FLCN- mutated neoplasms were diffusely immunoreactive for glycoprotein nonmetastatic B (GPNMB), but so were 3 of the 6 morphologically similar cases in which FLCN mutations were not detected. The 2 syndromic cases with adequate surrounding kidney for evaluation demonstrated GPNMB-positive cysts lined by cells with similar cytology to that of the neoplasms, possibly representing precursor lesions. In summary, histiocyte-rich renal epithelial neoplasm is a morphologic pattern that is strongly but not invariably associated with FLCN mutations. Recognition of this pattern is helpful in that it may provide the first clue to the presence of occult Birt-Hogg-Dubé syndrome.Keywords
This publication has 34 references indexed in Scilit:
- FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneityVirchows Archiv, 2025
- Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMTHuman Pathology, 2025
- Renal Neoplasia in Birt-Hogg-Dubé Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic AnalysisEuropean Urology, 2025
- ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2023
- Correspondence on “Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population” by Savatt et alGenetics in Medicine, 2022
- ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2022
- Frequency of truncating FLCN variants and Birt-Hogg-Dubé–associated phenotypes in a health care system populationGenetics in Medicine, 2022
- GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasmsThe Journal of Pathology, 2022
- Next-generation RNA Sequencing–based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic NeoplasmsEuropean Urology, 2020
- Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé SyndromeThe American Journal of Pathology, 2016